Vendor, Denver, CO
Colorado Serum Company
UEI JZGMQU7NXDB7, CAGE 63621
2 awards and $25,990 obligated between September 9, 2024 and April 25, 2025, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Biological Product (except Diagnostic) ManufacturingNAICS 325414 | $25,990 |
How it wins
Awards by competition, set-aside and type.
| Not Competed | 2 |
| Purchase Order | 2 |
Hear when Colorado Serum Company wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Colorado Serum Company's contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling biological product (except diagnostic) manufacturing to Animal and Plant Health Inspection Service, by dollars.
| Boehringer Ingelheim Animal Health USA Inc.Duluth, GA | $21,964,219 |
| Artemis Technologies Inc.Guelph | $20,263,540 |
| Boehringer Ingelheim Animal Health FranceLyon | $13,855,000 |
| Biogenesis Bago S.A.Garin | $3,112,499 |
| Covetrus North America, LLCDublin, OH | $1,414,943 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 12639524P0349Purchase Order, September 9, 2024, Not Competed, 1 offers | MRPBS Minneapolis MNAnimal and Plant Health Inspection Service | BCG and Placebo VaccineNAICS 325414, PSC 6509 | $38,750 |
| 12639523P0318Purchase Order, April 25, 2025, Not Competed, 1 offers | MRPBS Minneapolis MNAnimal and Plant Health Inspection Service | Closeout and De-Obligation of Remaining FundsNAICS 325414, PSC 6509 | -$12,760 |
- Product and service codes
- 6509 Drugs and Biologicals, Veterinary Use.
- Transactions
- 2 across 2 awards